303 - Association between Angiotensin II Antagonism and Mortality after LVAD Implantation: A Multi-Center, Contemporary Analysis
Presentation Number
303
Session Name
SESSION 77 - ORAL: Optimal Drug Therapy and Monitoring of MCS Patients
Date
Sat, Apr 25, 2020
Time
12:30 PM - 02:15 PM
Authors
- J. Schultz, Minneapolis, MN, United States of America
- B. Trachtenberg, Houston, TX, United States of America
- J. Estep, Cleveland, OH, United States of America
- K. Goodwin, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- A. El Rafei, Minneapolis, MN, United States of America
- T. Alexy, Minneapolis, MN, United States of America
- A. Shaffer, Minneapolis, MN, United States of America
- R. John, Minneapolis, MN, United States of America
- R. Cogswell, Minneapolis, MN, United States of America